Rubius Therapeutics Layoffs

Recent News and Discussions About Rubius Therapeutics Layoffs

Rubius Therapeutics kicks off $155M renovation of former …

https://www.fiercepharma.com/manufacturing/rubius-therapeutics-kicks-off-155m-renovation-former-alexion-plant-r-i

Rubius Therapeutics kicks off $155M renovation of former ...
The new facility will employ about 160 new positions versus the 250 full-time positions that were eliminated when Alexion announced it was closing the plant …


Working at Rubius Therapeutics | Glassdoor

https://www.glassdoor.com/Overview/Working-at-Rubius-Therapeutics-EI_IE2064074.11,30.htm

See what employees say it’s like to work at Rubius Therapeutics . Salaries, reviews, and more – all posted by employees working at Rubius Therapeutics .


Rubius touts new data for lead program, but shares routed as …

AACR22: Rubius touts new data for lead program, but shares routed as investors flee

Rubius ‘ shares plunged 40% once the data hit, with trading on the stock swiftly halted in the melee. The stock is down 86% over the past year, which has been …


Flagship woos another Big Pharma BD exec to biotech. Red …

Flagship woos another Big Pharma BD exec to biotech. Red blood cell therapies anyone?

He will now become Rubius Therapeutics ‘ chief business officer, … then thousands of medical product reviewers that the FDA would likely be laid off .


Rubius to pay $8m for ex-Soliris plant with troubled past

https://www.biopharma-reporter.com/Article/2018/07/27/Rubius-to-pay-8m-for-ex-Soliris-plant-with-troubled-past

Jul 27, 2018 — Rubius Therapeutics plans to invest $155m​ over a five-plus year period … facility and layoff 20% of its workforce in September last year, …


Stay alive': Wave of layoffs crashes into biotech startup …

http://www.cafepharma.com/boards/posts/6669336/

Mar 28, 2022 · 1 post He’s now founder of Sci.bio, a Boston-area biopharma recruitment and executive search firm that’s worked with Rubius Therapeutics , …


With data looming, Rubius Therapeutics seeks to shed its …

With data on a cancer drug derived from red blood cells looming, Rubius Therapeutics seeks to shed its bumbling image

Mar 9, 2021 — With data on a cancer drug derived from red blood cells looming, Rubius Therapeutics seeks to shed its bumbling image. Adam Feuerstein.


Rubius Therapeutics: Home

Home

Rubius Therapeutics | Red Cell TherapeuticsTM️ | Home Rubius Therapeutics is realizing the power of red by creating red blood cells and transforming them …


Rubius Therapeutics Reports Third Quarter 2021 Financial

https://www.globenewswire.com/news-release/2021/11/08/2329769/0/en/Rubius-Therapeutics-Reports-Third-Quarter-2021-Financial-Results-and-Provides-Business-Update.html

Nov 8, 2021 — Along with this leadership change, chief medical officer Christina Coughlin, M.D., Ph.D., will be leaving Rubius Therapeutics to pursue another …


Rubius Drops Rare Diseases, Turns to Cancer and … – Xconomy

https://xconomy.com/boston/2020/03/12/rubius-drops-rare-diseases-turns-to-cancer-and-autoimmune-disorders/

Mar 12, 2020 — Rubius Therapeutics is dropping its lead drug candidate—and its focus on rare diseases—in favor of earlier-stage cell therapies that it has …


Leave a Comment